Recent Updates
Recently added Catalysts
LNTH Positive Sentiment Score: 75/100

Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Wednesday, August 28, 2024 1 min read
Key Takeaway: Lantheus Holdings, Inc. has announced that its CEO, Brian Markison, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024. The presentation will highlight Lantheus's focus on radiopharmaceuticals aimed at improving patient outcomes. Investors and interested parties can access the live webcast via the company's website, with a replay available for 30 days following the event. The company, headquartered in Massachusetts, has a long history in providing radiopharmaceutical solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus continues to be a leader in the radiopharmaceutical field.
  • The upcoming presentation highlights the company's commitment to improving patient outcomes.
  • The webcast allows for broader access to the company's developments.

Full Press Release Details

BEDFORD, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 7:45 a.m. ET on Wednesday, September 4.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Vice President, Investor Relations
Senior Director, External Communications

Frequently Asked Questions

When will Lantheus present at the Morgan Stanley Conference?

Lantheus will present on September 4, 2024, at 7:45 a.m. ET.

How can I watch Lantheus's presentation live?

The live webcast can be accessed on Lantheus's Investors section at www.lantheus.com.

Will there be a replay of the webcast?

Yes, a replay will be available for at least 30 days after the presentation.

What is Lantheus focused on?

Lantheus focuses on radiopharmaceuticals to improve disease detection and management.

Where is Lantheus headquartered?

Lantheus is headquartered in Bedford, Massachusetts.

Tags: LNTH Viatris Investor Conferences Healthcare Lantheus Morgan Stanley radiopharmaceuticals healthcare conference
Last updated: Aug 28, 2024